Genetic Engineering News and Research

RSS

Delving into tumor's cellular lineage may offer clues for customized therapies

To explain a person's actions in the present, it sometimes helps to understand their past, including where they come from and how they were raised.

25 Apr 2019

UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

University of Alabama at Birmingham researchers will receive $17.8 million in federal funding to attack a key "knowledge gap" in human immunology -- how the B cells and antibody-secreting cells that reside in tissues and organs differ from those found in blood.

23 Apr 2019

Scientific breakthrough provides new hope for people living with multiple sclerosis

A scientific breakthrough provides new hope for millions of people living with multiple sclerosis. Researchers at Oregon Health & Science University have developed a compound that stimulates repair of the protective sheath that covers nerve cells in the brain and spinal cord.

19 Apr 2019

Drug that treats high blood pressure shows promise against neurodegenerative diseases

A prescribed drug to treat high blood pressure has shown promise against conditions such as Parkinson's, Huntington's and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge.

19 Apr 2019

Novel system enables researchers to study bacteria within mini-tissues in a dish

Engineering bacteria to intelligently sense and respond to disease states, from infections to cancer, has become a promising focus of synthetic biology.

19 Apr 2019

IDT partners with iGEM to support young researchers and promote scientific progress

As an advocate for researchers in synthetic biology, Integrated DNA Technologies is once again proudly partnering with the International Genetically Engineered Machine Foundation to support young researchers and promote scientific progress.

From Integrated DNA Technologies 17 Apr 2019

Novel serum biomarkers to detect NAFLD-related fibrosis

With an estimated 25% of people worldwide affected by nonalcoholic fatty liver disease (NAFLD), there is a large unmet need for accurate, noninvasive measures to enhance early diagnosis and screening of hepatic fibrosis.

16 Apr 2019

Growth hormone acts directly on the brain to conserve energy when the body loses weight

Researchers at the University of São Paulo in Brazil have discovered that growth hormone (GH), which stimulates skeletal maturation and linear bone growth, as well as helping maintain tissue and organs throughout life, also acts directly on the brain to conserve energy when the body loses weight.

12 Apr 2019

New genetic treatment removes antibiotic resistance from bacteria

Jane and Aatos Erkko foundation has awarded University of Jyväskylä'sAcademy Research Fellow Matti Jalasvuori's research group 255 000 euro grant for investigating the conjugative transfer of anti-antibiotic resistance genetic elements.

12 Apr 2019

Researchers identify rare SRC-1 gene variants related to human obesity

Maintaining a healthy body weight is no simple matter. A better understanding of how the body regulates appetite could help tip the scale toward the healthy side.

12 Apr 2019

Ohio researchers investigate racial disparity in non-alcoholic fatty liver disease

Two top researchers at the Ohio University Heritage College of Osteopathic Medicine are working with two other institutions on a federally funded project to investigate why Hispanics are more prone to develop non-alcoholic fatty liver disease.

12 Apr 2019

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

Researchers from the Experimental Oncology Group, led by Mariano Barbacid at the Spanish National Cancer Research Centre, have published in Cancer Cell the results of a study that shows full regression of advanced pancreatic ductal adenocarcinoma upon combined inhibition of the epidermal growth factor receptor and c-RAF kinase.

12 Apr 2019

Experimental drug may be twice as good at fighting vision loss as previously thought

In studies with lab-grown human cells and in mice, Johns Hopkins Medicine researchers have found that an experimental drug may be twice as good at fighting vision loss as previously thought.

11 Apr 2019

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

A DNA-encoded monoclonal antibody prevents Zika infection in mice and non-human primates, researchers report April 5 in the journal Molecular Therapy.

8 Apr 2019

Promising diagnostic, prognostic tools for onset and progression of ALS

Amyotrophic lateral sclerosis is a motor neuron disease with rampant progression and that it is typically fatal within 5 years of prognosis.

5 Apr 2019

Study compares use of breast milk to formula in children who underwent bone marrow transplant

A new pilot study compared the use of human breast milk to formula in children less than 5 years of age who underwent bone marrow transplant (BMT), measuring the levels of inflammatory and pro-inflammatory biomarkers in the stool and blood to assess inflammatory injury to the intestinal microbiome.

5 Apr 2019

Researchers engineer a promising treatment for African sleeping sickness

Researchers have turned a fungus into a disease-curing factory through modern genetic engineering and patience.

4 Apr 2019

Popular weed killer’s alleged link to cancer spreads concern

Clumps of dandelions have popped up in your yard, so you reach for a bottle of Roundup, the popular weed killer. It is known for being very effective, but its main ingredient, glyphosate, is getting a lot of attention because of lawsuits alleging links to cancer.

4 Apr 2019

New technology could change the way gene editing is approached in future

Gene editing has been a much sought after and controversial technology. Last month, part of the World Health Organization called for an international registry to track all research into editing the human genome.

4 Apr 2019

Study reveals vitamin B12 as inhibitor of key enzyme in hereditary Parkinson's disease

Iban Ubarretxena, an Ikerbasque Researcher and Director of the Biofisika Institute, participates in a piece of research that has enabled new inhibitors to be identified and which could be used to develop drugs to combat Parkinson's.

3 Apr 2019

Genetic Engineering News and Research

Delving into tumor's cellular lineage may offer clues for customized therapies

UAB receives $17 million grant to explore immune cells in inaccessible tissues of the human body

Scientific breakthrough provides new hope for people living with multiple sclerosis

Drug that treats high blood pressure shows promise against neurodegenerative diseases

Novel system enables researchers to study bacteria within mini-tissues in a dish

IDT partners with iGEM to support young researchers and promote scientific progress

Novel serum biomarkers to detect NAFLD-related fibrosis

Growth hormone acts directly on the brain to conserve energy when the body loses weight

New genetic treatment removes antibiotic resistance from bacteria

Researchers identify rare SRC-1 gene variants related to human obesity

Ohio researchers investigate racial disparity in non-alcoholic fatty liver disease

Combined inhibition of EGFR and c-RAF kinase shows regression of most aggressive pancreatic cancer

Experimental drug may be twice as good at fighting vision loss as previously thought

Synthetic antibody rapidly prevents Zika infection in mice and non-human primates

Promising diagnostic, prognostic tools for onset and progression of ALS

Study compares use of breast milk to formula in children who underwent bone marrow transplant

Researchers engineer a promising treatment for African sleeping sickness

Popular weed killer’s alleged link to cancer spreads concern

New technology could change the way gene editing is approached in future

Study reveals vitamin B12 as inhibitor of key enzyme in hereditary Parkinson's disease

Biochemistry eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo